Literature DB >> 2991534

Molecular movements promoted by metal nucleotides in the heavy-chain regions of myosin heads from skeletal muscle.

D Mornet, P Pantel, E Audemard, J Derancourt, R Kassab.   

Abstract

Molecular movements generated in the heavy-chain regions (27-50-20(X 10(3)) Mr) of myosin S1 on interaction with nucleotides ATP, AMPPNP, ADP and PPi were investigated by limited proteolysis of several enzyme-metal nucleotide complexes in the absence and presence of reversibly bound and crosslinked F-actin. The rate and extent of the nucleotide-promoted conversion of the NH2-terminal 27 X 10(3) Mr and 50 X 10(3) Mr segments into products of 22 X 10(3) Mr and 45 X 10(3) Mr, respectively, were estimated to determine the amplitude of the molecular movements. The 22 X 10(3) Mr peptide was identified by amino acid sequence studies as being derived from cleavage of the peptide bond between Arg and Ile (at position 23 to 24). The 45 X 10(3) Mr peptide, previously shown to represent the NH2-terminal part of the 50 X 10(3) Mr region, would be connected to the adjacent C-terminal 20 X 10(3) Mr region by a pre-existing loop segment of about 5 X 10(3) Mr; the proteolytic sensitivity of the latter region is increased particularly by nucleotide binding. The tryptic reaction proved to be a sensitive indicator of the conformational state of the liganded heavy chain as the rate of peptide bond cleavage in the two regions is dependent on the nature of the bound ligand; it decreases in the order: ATP greater than AMPPNP greater than ADP greater than PPi. It depends also on the nature of the metal present, Mg2+ and Ca2+ being much more effective than K+. Binding of F-actin to the S1-MgAMPPNP complex affords significant protection against breakdown of 27 X 10(3) Mr and 50 X 10(3) Mr peptides, but with concomitant hydrolysis of the 50 X 10(3) Mr-20 X 10(3) Mr junction. Additionally, interaction of MgATP with HMM modulates the tryptic fission of the S1-S2 region. The overall data provide a molecular support for the two-state model of the myosin head and emphasize the involvement of the 50 X 10(3) Mr unit in the mechanism of coupling between the actin and nucleotide binding sites.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991534     DOI: 10.1016/0022-2836(85)90015-4

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  Localization of epitopes and functional effects of two novel monoclonal antibodies against skeletal muscle myosin.

Authors:  M Dan-Goor; L Silberstein; M Kessel; A Muhlrad
Journal:  J Muscle Res Cell Motil       Date:  1990-06       Impact factor: 2.698

2.  Conformational changes in actin-myosin isoforms probed by Ni(II).Gly-Gly-His reactivity.

Authors:  Juliette Van Dijk; Chrystel Lafont; Menno L W Knetsch; Jean Derancourt; Dietmar J Manstein; Eric C Long; Patrick Chaussepied
Journal:  J Muscle Res Cell Motil       Date:  2005-02-09       Impact factor: 2.698

Review 3.  Domains, motions and regulation in the myosin head.

Authors:  P Vibert; C Cohen
Journal:  J Muscle Res Cell Motil       Date:  1988-08       Impact factor: 2.698

Review 4.  Pathway for the communication between the ATPase and actin sites in myosin.

Authors:  E Audemard; R Bertrand; A Bonet; P Chaussepied; D Mornet
Journal:  J Muscle Res Cell Motil       Date:  1988-06       Impact factor: 2.698

5.  Nucleotide and actin binding properties of the isolated motor domain from Dictyostelium discoideum myosin.

Authors:  A A Bobkov; K Sutoh; E Reisler
Journal:  J Muscle Res Cell Motil       Date:  1997-10       Impact factor: 2.698

6.  An intact heavy chain at the actin-subfragment 1 interface is required for ATPase activity of scallop myosin.

Authors:  E M Szentkiralyi
Journal:  J Muscle Res Cell Motil       Date:  1987-08       Impact factor: 2.698

7.  Both the 25-kDa and 50-kDa domains in myosin subfragment 1 are close to the reactive thiols.

Authors:  R C Lu; L Moo; A G Wong
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.